v3.25.1
Stockholders' equity (Tables)
9 Months Ended
Mar. 31, 2025
Equity [Abstract]  
Schedule of warrants or rights
The activity related to warrants for the nine months ended March 31, 2025, is summarized as follows:
 
     Common
Stock from
Warrants
     Weighted-
average
Exercise
Price (per
share)
 
Outstanding at July 1, 2024
     34,271,146      $ 1.85  
Pre-funded
warrants exercised
     1,768,454      $ 0.0001  
Series 2 warrants exercised
     857,845      $ 1.9299  
Common warrants exercised
     5,181,347      $ 3.86  
  
 
 
    
 
 
 
Outstanding and exercisable at September 30, 2024
     26,463,500      $ 1.57  
  
 
 
    
 
 
 
Pre-funded
warrants exercised
     606,129      $ 0.0001  
Series 2 warrants exercised
     642,160      $ 1.9299  
Common warrants exercised
     4,309,421      $ 3.86  
Purchase warrants expired
     6,300      $ 178.50  
  
 
 
    
 
 
 
Outstanding and exercisable at December 31, 2024
     20,899,490      $ 1.08  
Pre-funded
warrants issued March 25, 2025
     300,000      $ 0.0001  
Common warrants exercised
     51,813      $ 3.86  
  
 
 
    
 
 
 
Outstanding and exercisable at March 31, 2025
     21,147,677      $ 1.06  
  
 
 
    
 
 
 
Schedule of equity awards
The activity related to equity awards, which are comprised of stock options during the nine months ended March 31, 2025 is summarized as follows:
 
     Stock
Options
     Weighted-
average
Exercise
Price
     Weighted-
average
Remaining
Contractual
Term
     Aggregate
Intrinsic
Value
 
Outstanding at June 30, 2024
     1,182,140      $ 6.58        9.51 years      $ 2,342,847  
Granted
     3,470,000        12.16        9.94 years        1,615,500  
Expired
     —         —         —         —   
Forfeited
     —         —         —         —   
  
 
 
    
 
 
    
 
 
    
 
 
 
Outstanding at March 31, 2025
     4,652,140      $ 10.75        9.46 years      $ 12,160,372  
Exercisable at March 31, 2025
     628,669      $ 10.42        8.95 years      $ 3,258,553  
Schedule of equity-based compensation expense
The classification of share-based compensation expense is summarized as follows:
 
     Three Months Ended      Nine Months Ended  
     March 31,  
(US$’000)    2025      2024      2025      2024  
Research and development
   $ 302      $ 45      $ 538      $ 112  
General and administrative
     2,295        147        3,437        264  
  
 
 
    
 
 
    
 
 
    
 
 
 
Total share-based compensation expense
   $ 2,597      $ 192      $ 3,975      $ 376